Liver transplantation for acute liver failure due to antitubercular drugs - a single-center experience

Clinics
Rodrigo Bronze de MartinoAlice Tung Wan Song

Abstract

Patients receiving treatment for tuberculosis are at risk of developing acute liver failure due to the hepatotoxicity of antitubercular drugs. We aimed to describe our experience with liver transplantation from deceased donors in this situation. We identified patients undergoing transplantation for acute liver failure due to antitubercular drugs in our prospectively maintained database. Of 81 patients undergoing transplantation for acute liver failure, 8 cases were attributed to antitubercular drugs during the period of 2006-2016. Regarding the time of tuberculosis treatment until the onset of jaundice, patients were on antitubercular drugs for a mean of 64.7 days (21-155 days). The model for end-stage liver disease (MELD) score of patients ranged from 32 to 47 (median 38), and seven patients underwent transplantation under vasopressors. The 1-year survival was 50%. Three patients died during the week following transplantation due to septic shock (including a patient with acute liver failure due to hepatic/disseminated tuberculosis), and the remaining patient died 2 months after transplantation due to pulmonary infection. There were 2 cases of mild rejection and 1 case of moderate rejection. Of the surviving patients, all were ...Continue Reading

References

Aug 1, 1989·Gastroenterology·J G O'GradyR Williams
Mar 4, 1995·Lancet·I MitchellR Williams
May 1, 1995·Gut·W HussainJ Neuberger
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Peter FerenciAndres T Blei
Nov 13, 2007·Journal of Gastroenterology and Hepatology·Alma TostmannRichard Dekhuijzen
Jul 20, 2010·Lancet·William BernalJulia Wendon
Sep 30, 2010·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Philippe IchaiDidier Samuel
Apr 24, 2012·Journal of Hepatology·Giacomo GermaniAndrew K Burroughs
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S A FischerUNKNOWN AST Infectious Diseases Community of Practice
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A K SubramanianUNKNOWN AST Infectious Diseases Community of Practice
Mar 13, 2014·Transplant International : Official Journal of the European Society for Organ Transplantation·Dieter P HoyerFuat H Saner
May 20, 2015·Oxford Medical Case Reports·Deepak JainSunil Pawar
Oct 6, 2015·Case Reports in Infectious Diseases·Tayfur ToptasTulin Firatli-Tuglular
Jan 29, 2016·World Journal of Gastroenterology : WJG·Manuel Mendizabal, Marcelo Oscar Silva
Dec 23, 2016·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jin-Young HuhKyung-Wook Jo
Jan 6, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Michele BartolettiPierluigi Viale
Jan 10, 2017·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Akshay P BavikatteRamachandran N Menon

❮ Previous
Next ❯

Citations

Feb 15, 2019·Indian Journal of Pediatrics·Joseph L Mathew

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.